← Open Payments lookup

JESSICA SCAMPONE: Open Payments

NPI 1326536418 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,837 in 72 payments from 20 companies in 2025. Trend: 2023 $942 · 2024 $1,497 · 2025 $1,837

Food & beverage: $1,747Education: $90
CompanyPaymentsAmount
GlaxoSmithKline, LLC.14$402
AstraZeneca Pharmaceuticals LP15$301
Insmed, Inc.7$160
Regeneron Healthcare Solutions, Inc.3$145
Grifols USA, LLC5$131
Verona Pharma, Inc.7$114
INTUITIVE SURGICAL, INC.1$77
Takeda Pharmaceuticals U.S.A., Inc.2$67
Axsome Therapeutics, Inc.2$63
Avadel CNS Pharmaceuticals, LLC2$53

Products named: NUCALA, DUPIXENT, Arikayce, Prolastin-C Liquid, AREXVY, FASENRA, Ohtuvayre, TEZSPIRE.

Industry payments across MD — which companies pay providers there.